These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9627710)

  • 1. The mouse skin carcinogenesis model.
    Slaga TJ; Budunova IV; Gimenez-Conti IB; Aldaz CM
    J Investig Dermatol Symp Proc; 1996 Apr; 1(2):151-6. PubMed ID: 9627710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin carcinogenesis: characteristics, mechanisms, and prevention.
    Slaga TJ; DiGiovanni J; Winberg LD; Budunova IV
    Prog Clin Biol Res; 1995; 391():1-20. PubMed ID: 8532708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical genetic determinants and molecular events in multistage skin carcinogenesis.
    Slaga TJ; O'Connell J; Rotstein J; Patskan G; Morris R; Aldaz CM; Conti CJ
    Symp Fundam Cancer Res; 1986; 39():31-44. PubMed ID: 3321308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in protein expression during multistage mouse skin carcinogenesis.
    Rundhaug JE; Gimenez-Conti I; Stern MC; Budunova IV; Kiguchi K; Bol DK; Coghlan LG; Conti CJ; DiGiovanni J; Fischer SM; Winberg LD; Slaga TJ
    Mol Carcinog; 1997 Sep; 20(1):125-36. PubMed ID: 9328443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
    Budunova IV; Carbajal S; Viaje A; Slaga TJ
    Mol Carcinog; 1996 Mar; 15(3):190-201. PubMed ID: 8597532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diverse tumor promoters on the expression of gap-junctional proteins connexin (Cx)26, Cx31.1, and Cx43 in SENCAR mouse epidermis.
    Budunova IV; Carbajal S; Slaga TJ
    Mol Carcinog; 1996 Mar; 15(3):202-14. PubMed ID: 8597533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
    Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC; Benavides F; LaCava M; Conti CJ
    Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Slaga TJ
    Carcinogenesis; 1995 Nov; 16(11):2717-24. PubMed ID: 7586191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased telomerase activity in mouse skin premalignant progression.
    Bednarek A; Budunova I; Slaga TJ; Aldaz CM
    Cancer Res; 1995 Oct; 55(20):4566-9. PubMed ID: 7553630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas.
    Aldaz CM; Conti CJ; Larcher F; Trono D; Roop DR; Chesner J; Whitehead T; Slaga TJ
    Cancer Res; 1988 Jun; 48(11):3253-7. PubMed ID: 2452689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
    Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for initiated mouse skin: suppression of papilloma but not carcinoma formation by normal epidermal cells in grafts on athymic nude mice.
    Strickland JE; Ueda M; Hennings H; Yuspa SH
    Cancer Res; 1992 Mar; 52(6):1439-44. PubMed ID: 1540951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas.
    Klein-Szanto AJ; Nelson KG; Shah Y; Slaga TJ
    J Natl Cancer Inst; 1983 Jan; 70(1):161-8. PubMed ID: 6185712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis during papilloma development in mice susceptible to tumor progression.
    Stern MC; Durán HA; McKenna EA; Conti CJ
    Mol Carcinog; 1997 Sep; 20(1):137-42. PubMed ID: 9328444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.